HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS • US4330001060
16.48 USD
+1.96 (+13.5%)
At close: Mar 2, 2026
16.42 USD
-0.06 (-0.36%)
After Hours: 3/2/2026, 7:00:00 PM
We assign a fundamental rating of 4 out of 10 to HIMS. HIMS was compared to 101 industry peers in the Health Care Providers & Services industry. While HIMS is still in line with the averages on profitability rating, there are concerns on its financial health. HIMS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- HIMS had positive earnings in the past year.
- HIMS had a positive operating cash flow in the past year.
- In multiple years HIMS reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
- HIMS has a Return On Assets of 5.96%. This is amongst the best in the industry. HIMS outperforms 81.19% of its industry peers.
- With an excellent Return On Equity value of 23.73%, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
- HIMS has a Return On Invested Capital (5.49%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.96% | ||
| ROE | 23.73% | ||
| ROIC | 5.49% |
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 5.47%, HIMS belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
- HIMS's Operating Margin of 5.18% is fine compared to the rest of the industry. HIMS outperforms 64.36% of its industry peers.
- HIMS has a better Gross Margin (73.83%) than 89.11% of its industry peers.
- HIMS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.18% | ||
| PM (TTM) | 5.47% | ||
| GM | 73.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
- HIMS has more shares outstanding than it did 1 year ago.
- HIMS has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for HIMS is higher compared to a year ago.
2.2 Solvency
- HIMS has an Altman-Z score of 2.63. This is not the best score and indicates that HIMS is in the grey zone with still only limited risk for bankruptcy at the moment.
- HIMS has a Altman-Z score (2.63) which is comparable to the rest of the industry.
- The Debt to FCF ratio of HIMS is 16.94, which is on the high side as it means it would take HIMS, 16.94 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 16.94, HIMS perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
- A Debt/Equity ratio of 1.80 is on the high side and indicates that HIMS has dependencies on debt financing.
- HIMS has a Debt to Equity ratio of 1.80. This is in the lower half of the industry: HIMS underperforms 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.8 | ||
| Debt/FCF | 16.94 | ||
| Altman-Z | 2.63 |
ROIC/WACC0.68
WACC8.08%
2.3 Liquidity
- A Current Ratio of 1.90 indicates that HIMS should not have too much problems paying its short term obligations.
- HIMS has a Current ratio of 1.90. This is amongst the best in the industry. HIMS outperforms 80.20% of its industry peers.
- HIMS has a Quick Ratio of 1.70. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.70, HIMS is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.7 |
3. Growth
3.1 Past
- HIMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.41%.
- Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 59.00%.
- Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 64.55% on average per year.
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%
3.2 Future
- The Earnings Per Share is expected to grow by 51.33% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 12.27% on average over the next years. This is quite good.
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 32.96, which means the current valuation is very expensive for HIMS.
- HIMS's Price/Earnings ratio is in line with the industry average.
- HIMS's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.13.
- The Price/Forward Earnings ratio is 28.35, which means the current valuation is very expensive for HIMS.
- The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
- The average S&P500 Price/Forward Earnings ratio is at 28.11. HIMS is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.96 | ||
| Fwd PE | 28.35 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
- HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 65.34 | ||
| EV/EBITDA | 19.02 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- A more expensive valuation may be justified as HIMS's earnings are expected to grow with 68.86% in the coming years.
PEG (NY)2.02
PEG (5Y)N/A
EPS Next 2Y26.07%
EPS Next 3Y68.86%
5. Dividend
5.1 Amount
- HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
16.48
+1.96 (+13.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners94.2%
Inst Owner Change-9.78%
Ins Owners5.93%
Ins Owner Change31.2%
Market Cap3.75B
Revenue(TTM)2.35B
Net Income(TTM)128.37M
Analysts67.27
Price Target30 (82.04%)
Short Float %37.45%
Short Ratio3.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.11%
Min EPS beat(2)-43.53%
Max EPS beat(2)49.74%
EPS beat(4)3
Avg EPS beat(4)19.67%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)137.04%
EPS beat(12)10
Avg EPS beat(12)108.42%
EPS beat(16)13
Avg EPS beat(16)83.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.24%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)12
Avg Revenue beat(16)2.47%
PT rev (1m)-32.52%
PT rev (3m)-38.93%
EPS NQ rev (1m)0.58%
EPS NQ rev (3m)-8.79%
EPS NY rev (1m)-0.58%
EPS NY rev (3m)-28.24%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)-1.03%
Revenue NY rev (3m)-1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.96 | ||
| Fwd PE | 28.35 | ||
| P/S | 1.6 | ||
| P/FCF | 65.34 | ||
| P/OCF | 12.51 | ||
| P/B | 6.94 | ||
| P/tB | 56.43 | ||
| EV/EBITDA | 19.02 |
EPS(TTM)0.5
EY3.03%
EPS(NY)0.58
Fwd EY3.53%
FCF(TTM)0.25
FCFY1.53%
OCF(TTM)1.32
OCFY8%
SpS10.31
BVpS2.38
TBVpS0.29
PEG (NY)2.02
PEG (5Y)N/A
Graham Number5.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.96% | ||
| ROE | 23.73% | ||
| ROCE | 6.95% | ||
| ROIC | 5.49% | ||
| ROICexc | 8.2% | ||
| ROICexgc | 13.77% | ||
| OM | 5.18% | ||
| PM (TTM) | 5.47% | ||
| GM | 73.83% | ||
| FCFM | 2.45% |
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
F-Score5
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.8 | ||
| Debt/FCF | 16.94 | ||
| Debt/EBITDA | 5.52 | ||
| Cap/Depr | 445.11% | ||
| Cap/Sales | 10.33% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 170.27% | ||
| Profit Quality | 44.73% | ||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.7 | ||
| Altman-Z | 2.63 |
F-Score5
WACC8.08%
ROIC/WACC0.68
Cap/Depr(3y)344.08%
Cap/Depr(5y)250.41%
Cap/Sales(3y)5.65%
Cap/Sales(5y)4.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
EBIT growth 1Y78.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year223.89%
EBIT Next 3Y71.72%
EBIT Next 5Y48.01%
FCF growth 1Y-71.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.48%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 5 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.